Telix Pharmaceuticals Ltd (TLX) stock
TLXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as TLPPF
$9.23−0.13 (-1.39%)
Close on Nov 13, 2026Market cap $3.13BP/E –Yield –
Telix Pharmaceuticals statistics
78 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Jun 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
Enterprise valuationIndustry
- EV / Sales
- 4.22
- 2.57
- EV / EBIT
- 113.90
- 19.31
Share statisticsIndustry
- Shares Change (YoY)
- -2.12%
- 10.8%
- Float
- 311M
- 49M
- Shares Held by Insiders
- 8.26%
- 11.7%
- Shares Held by Institutions
- 0.94%
- 56.4%
Short sellingIndustry
- Short Interest
- 270,623
- –
- Short Interest Change
- -23.3%
- -0.80%
- Days to Cover
- 1.00
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $13.11
- –
- 52-Week Low
- $6.28
- –
- 20-Day Moving Average
- $9.55
- –
- 50-Day Moving Average
- $10.67
- –
- 200-Day Moving Average
- $9.99
- –
- Average True Range (14)
- $0.38
- –
- Price Change (1 Week)
- -4.15%
- -1.15%
- Price Change (1 Month)
- -12.7%
- -4.87%
- Price Change (3 Months)
- -21.3%
- -21.0%
- Price Change (6 Months)
- -12.6%
- -20.6%
- Price Change (YTD)
- 23.2%
- -23.6%
- Price Change (1 Year)
- -5.91%
- -22.4%
- Average Volume (10 Days)
- 282,020
- –
- Average Volume (20 Days)
- 337,380
- –
- Average Volume (90 Days)
- 280,204
- –
- Relative Volume
- 0.39
- 0.70
- Relative Strength Index (14)
- 41.6
- 43.4
- Volatility (1 Year)
- 56.6%
- 80.1%
- Beta (5 Years)
- 1.45
- 1.07
MarginsIndustry
- Pretax Margin
- -0.66%
- -11.6%
- EBITDA Margin
- 6.37%
- -27.7%
- FCF Margin
- -5.35%
- -9.56%
Returns on capitalIndustry
- Return on Assets (ROA)
- -0.52%
- -40.6%
- Return on Capital Employed (ROCE)
- 2.66%
- -37.9%
Financial positionIndustry
- Current Ratio
- 2.01
- 3.30
- Quick Ratio
- 1.71
- 2.39
- Debt / EBITDA
- 10.09
- 3.15
- Net Debt / EBITDA
- 5.17
- 1.97
- Interest Coverage
- 0.73
- -6.35
GrowthIndustry
- Revenue Growth (YoY)
- 55.6%
- 6.82%
- Net Income Growth (YoY)
- -121.2%
- -14.4%
- EPS Growth (YoY)
- -121.6%
- -12.3%
- FCF Growth (YoY)
- -334.0%
- 6.85%
EfficiencyIndustry
- Asset Turnover
- 0.59
- 0.40
- Inventory Turnover
- 9.67
- 2.73
- Revenue Per Employee
- $717.67K
- $429.29K
- Profits Per Employee
- -$6.36K
- -$689.41K
- Employee Count
- 1,120
- 74
- WACC
- 11.5%
- 10.2%
Income statement (TTM)Industry
- Pretax Income
- -$5.27M
- -$12.95M
Balance sheetIndustry
- Net Cash (Debt)
- -$264.48M
- $17.76M
- Net Cash Per Share
- -$0.78
- $0.80
- Working Capital
- $245.68M
- $79.99M
Cash flow (TTM)Industry
- Capital Expenditures
- -$25.69M
- -$1.00M
- FCF Per Share
- -$0.13
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- -0.23%
- -21.8%
- FCF Yield
- -1.37%
- -9.44%
Taxes and interestIndustry
- Interest Expense
- $40.87M
- $2.90M
- Income Tax
- $1.86M
- $73.00K
Scores and fair valueIndustry
- Altman Z-Score
- 2.91
- 0.23
- Piotroski F-Score
- 2
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | TLX | S&P 500 | Difference | TLX per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -15.5% | -3.0% | −12.4 pts | ||
| 3 months | -25.1% | -2.8% | −22.4 pts | ||
| Year to date | +23.2% | +11.5% | +11.7 pts | ||
| 1 year | -2.9% | +13.5% | −16.4 pts | ||
| 3 years | +3196.4% | +77.7% | +3118.7 pts | +220.6% | +21.1% |
| 5 years | +3196.4% | +72.6% | +3123.8 pts | +101.2% | +11.5% |
| 10 years | +3196.4% | +308.2% | +2888.3 pts | +41.8% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
0M TLX shares were sold short on Oct 30, 2026, down 23.3% from the previous report. At recent volumes it would take 1.0 days to buy them back. Over the last 20 sessions, 58.2% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 270,623 | -23.3% | 381,581 | 1.0 |
| Oct 15, 2026 | 352,936 | -17.3% | 320,751 | 1.1 |
| Sep 30, 2026 | 426,829 | +21.1% | 542,786 | 1.0 |
| Sep 15, 2026 | 352,524 | +33.1% | 400,077 | 1.0 |
| Aug 31, 2026 | 264,943 | +8.2% | 147,160 | 1.8 |
| Aug 14, 2026 | 244,900 | -11.8% | 106,104 | 2.3 |
| Jul 31, 2026 | 277,664 | -6.6% | 108,323 | 2.6 |
| Jul 15, 2026 | 297,140 | +82.7% | 165,030 | 1.8 |
| Jun 30, 2026 | 162,625 | -16.2% | 213,105 | 1.0 |
| Jun 15, 2026 | 193,969 | -22.8% | 235,552 | 1.0 |
| May 29, 2026 | 251,276 | +15.6% | 116,627 | 2.1 |
| May 15, 2026 | 217,298 | -19.5% | 116,382 | 1.9 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?